Cite
HARVARD Citation
Sarafidis, P. et al. (2020). SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrology dialysis transplantation. 35 (10), p. 1825. [Online].